Top

BMC Pregnancy and Childbirth

Published in:

Open Access 01-12-2021 | SARS-CoV-2 | Research

SARS-CoV-2 in diabetic pregnancies: a systematic scoping review

Authors: Claudia Eberle, Tamarra James-Todd, Stefanie Stichling

Published in: BMC Pregnancy and Childbirth | Issue 1/2021

Abstract

Background

Currently, we suffer from an increasing diabetes pandemic and on the other hand from the SARS-CoV-2 pandemic. Already at the beginning of the SARS-CoV-2 pandemic, it was quickly assumed that certain groups are at increased risk to suffer from a severe course of COVID-19. There are serious concerns regarding potential adverse effects on maternal, fetal, and neonatal outcomes. Diabetic pregnancies clearly need special care, but clinical implications as well as the complex interplay of diabetes and SARS-CoV-2 are currently unknown. We summarized the evidence on SARS-CoV-2 in diabetic pregnancies, including the identification of novel potential pathophysiological mechanisms and interactions as well as clinical outcomes and features, screening, and management approaches.

Methods

We carried out a systematic scoping review in MEDLINE (PubMed), EMBASE, CINAHL, Cochrane Library, and Web of Science Core Collection in September 2020.

Results

We found that the prognosis of pregnant women with diabetes mellitus and COVID-19 may be associated with potential underlying mechanisms such as a simplified viral uptake by ACE2, a higher basal value of pro-inflammatory cytokines, being hypoxemic as well as platelet activation, embolism, and preeclampsia. In the context of “trans-generational programming” and COVID-19, life-long consequences may be “programmed” during gestation by pro-inflammation, hypoxia, over- or under-expression of transporters and enzymes, and epigenetic modifications based on changes in the intra-uterine milieu. COVID-19 may cause new onset diabetes mellitus, and that vertical transmission from mother to baby might be possible.

Conclusions

Given the challenges in clinical management, the complex interplay between COVID-19 and diabetic pregnancies, evidence-based recommendations are urgently needed. Digital medicine is a future-oriented and effective approach in the context of clinical diabetes management. We anticipate our review to be a starting point to understand and analyze mechanisms and epidemiology to most effectively treat women with SARS-COV-2 and diabetes in pregnancy.

Available only for authorised users

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard: Data last updated: 2020/12/9, 9:34am CET. 2020. https://covid19.who.int/. Accessed 9 Dec 2020.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20:669–77. https://doi.org/10.1016/S1473-3099(20)30243-7.CrossRefPubMedPubMedCentral

Kleinwechter H, Laubner K. Coronavirus disease 2019 (COVID-19) and pregnancy: Overview and report of the first German case with COVID-19 and gestational diabetes. Diabetologe. 2020;16:242–6. https://doi.org/10.1007/s11428-020-00611-0.CrossRef

Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control. 2020. https://doi.org/10.1016/j.ajic.2020.06.213.CrossRefPubMedPubMedCentral

Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol. 2020;55:435–7. https://doi.org/10.1002/uog.22006.CrossRefPubMedPubMedCentral

Bahadur G, Homburg R, Yoong W, Singh C, Bhat M, Kotabagi P, et al. Adverse outcomes in SAR-CoV-2 (COVID-19) and SARS virus related pregnancies with probable vertical transmission. JBRA Assist Reprod. 2020;24:351–7. https://doi.org/10.5935/1518-0557.20200057.CrossRefPubMedPubMedCentral

Kleinwechter H. Diabetes and pregnancy—update 2020. Diabetologe. 2020;16:470–7. https://doi.org/10.1007/s11428-020-00629-4.CrossRef

International Diabetes Federation. IDF Diabetes Atlas 9th edition 2019. 2020. https://www.diabetesatlas.org/en/resources/. Accessed 25 Jun 2020.

World Health Organization. Diabetes. Fact sheet. 2020. https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed 31 Aug 2020.

10.

German Diabetes Association. Deutscher Gesundheitsbericht Diabetes 2020: Kirchheim + Co GmbH; 2020.

11.

International Diabetes Federation. IDF Diabetes Atlas. Worldwide toll of diabetes. 2020. https://www.diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html. Accessed 31 Aug 2020.

12.

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43:S14–31. https://doi.org/10.2337/dc20-S002.CrossRef

13.

Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(Suppl 2):S141–6. https://doi.org/10.2337/dc07-s206.CrossRefPubMed

14.

Zhu Y, Zhang C. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep. 2016;16:7. https://doi.org/10.1007/s11892-015-0699-x.CrossRefPubMedPubMedCentral

15.

Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40:899–909. https://doi.org/10.1007/s40618-016-0607-5.CrossRefPubMed

16.

Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London, England). 2009;373:1773–9. https://doi.org/10.1016/S0140-6736(09)60731-5.CrossRef

17.

Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009;301:842–7. https://doi.org/10.1001/jama.2009.201.CrossRefPubMed

18.

Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol. 2007;50:972–9. https://doi.org/10.1097/GRF.0b013e31815a61d6.CrossRefPubMed

19.

West NA, Crume TL, Maligie MA, Dabelea D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia. 2011;54:504–7. https://doi.org/10.1007/s00125-010-2008-1.CrossRefPubMed

20.

Tam WH, Ma RCW, Yang X, Ko GTC, Tong PCY, Cockram CS, et al. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics. 2008;122:1229–34. https://doi.org/10.1542/peds.2008-0158.CrossRefPubMed

21.

Eberle C. Fetale Programmierung des Diabetes mellitus Typ 2: Intrauterine Wachstumsretardierung als Risikofaktor? MMW-Fortschritte Der Medizin. 2010;152:76–82. https://doi.org/10.1007/BF03373173.CrossRefPubMed

22.

Eberle C, Ament C. Diabetic and metabolic programming: mechanisms altering the intrauterine milieu. ISRN Pediatr. 2012;2012: 975685. https://doi.org/10.5402/2012/975685.CrossRefPubMedPubMedCentral

23.

Eberle C, Ament C. A combined in vivo and in silico model shows specific predictors of individual trans-generational diabetic programming. J Dev Orig Health Dis. 2020:1–8. https://doi.org/10.1017/S2040174420000471.

24.

Eberle C, Stupin JH. 6.5 Perinatale Programmierung. In: Stupin J, Schäfer-Graf U, Hummel M, editors. Diabetes in der Schwangerschaft: Praxisorientiertes Wissen zu Gestationsdiabetes, Diabetes mellitus Typ 1 und 2, MODY. 1st ed.; 2020. p. 242–265. https://doi.org/10.1515/9783110569186-006.

25.

Eberle C, Merki E, Yamashita T, Johnson S, Armando AM, Quehenberger O, et al. Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes. PLoS One. 2012;7: e45361. https://doi.org/10.1371/journal.pone.0045361.CrossRefPubMedPubMedCentral

26.

Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, Palinski W. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res. 2006;99:e51-64. https://doi.org/10.1161/01.RES.0000244003.08127.cc.CrossRefPubMed

27.

Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141–6. https://doi.org/10.1097/XEB.0000000000000050.CrossRefPubMed

28.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6: e1000097. https://doi.org/10.1371/journal.pmed.1000097.CrossRefPubMedPubMedCentral

29.

Long Q-X, Tang X-J, Shi Q-L, Li Q, Deng H-J, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200–4. https://doi.org/10.1038/s41591-020-0965-6.CrossRefPubMed

30.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5. https://doi.org/10.1016/j.ijid.2020.03.017.CrossRefPubMedPubMedCentral

31.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8. https://doi.org/10.1007/s00392-020-01626-9.CrossRefPubMed

32.

Al-Salameh A, Lanoix J-P, Bennis Y, Andrejak C, Brochot E, Deschasse G, et al. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes Metab Res Rev. 2020. https://doi.org/10.1002/dmrr.3388.CrossRefPubMedPubMedCentral

33.

Hartmann-Boyce J, Morris E, Goyder C, Kinton J, Perring J, Nunan D, et al. Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters. Diabetes Care. 2020;43:1695–703. https://doi.org/10.2337/dc20-1192.CrossRefPubMed

34.

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020:e3319. https://doi.org/10.1002/dmrr.3319.

35.

Filardi T, Morano S. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? J Endocrinol Invest. 2020;43:1053–60. https://doi.org/10.1007/s40618-020-01318-1.CrossRefPubMedPubMedCentral

36.

Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020;43:1399–407. https://doi.org/10.2337/dc20-0660.CrossRefPubMed

37.

Tsai S, Clemente-Casares X, Zhou AC, Lei H, Ahn JJ, Chan YT, et al. Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection. Cell Metab. 2018;28:922-934.e4. https://doi.org/10.1016/j.cmet.2018.08.003.CrossRefPubMed

38.

Stegenga ME, van der Crabben SN, Blümer RME, Levi M, Meijers JCM, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008;112:82–9. https://doi.org/10.1182/blood-2007-11-121723.CrossRefPubMedPubMedCentral

39.

Gerste RD. Thrombose-Pathogenese: Endotheldysfunktion bei COVID-19. Dtsch Arztebl. 2020;117:22–3.

40.

Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, Eid AA. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev Endocr Metab Disord. 2020. https://doi.org/10.1007/s11154-020-09573-6.CrossRefPubMedPubMedCentral

41.

Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc. 2020;95:1138–47. https://doi.org/10.1016/j.mayocp.2020.04.006.CrossRefPubMed

42.

Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease, , et al. in pregnancy: living systematic review and meta-analysis. BMJ (Clinical research ed). 2019;2020(370): m3320. https://doi.org/10.1136/bmj.m3320.CrossRef

43.

Narang K, Enninga EAL, Gunaratne, Madugodaralalage DSK, Ibirogba ER, Trad ATA, Elrefaei A, et al. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. Mayo Clin Proc. 2020;95:1750–65. https://doi.org/10.1016/j.mayocp.2020.05.011.CrossRefPubMed

44.

Morris E, et al. Coronavirus (COVID-19) Infection in Pregnancy: 1Information for healthcare professionals. 11th ed.; 24.07.2020.

45.

Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99:823–9. https://doi.org/10.1111/aogs.13867.CrossRefPubMed

46.

Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020. https://doi.org/10.5858/arpa.2020-0901-SA.CrossRefPubMed

47.

Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.028.CrossRefPubMedPubMedCentral

48.

Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. New-Onset Diabetes in Covid-19. N Engl J Med. 2020;383:789–90. https://doi.org/10.1056/NEJMc2018688.CrossRefPubMed

49.

Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res Clin Pract. 2020. https://doi.org/10.1016/j.diabres.2020.108088.CrossRefPubMedPubMedCentral

50.

Gracia-Ramos AE. Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? Arch Med Res. 2020;51:345–6. https://doi.org/10.1016/j.arcmed.2020.03.011.CrossRefPubMedPubMedCentral

51.

Hecht JL, Quade B, Deshpande V, Mino-Kenudson M, Ting DT, Desai N, et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Modern Pathol. 2020. https://doi.org/10.1038/s41379-020-0639-4.

52.

Ferraiolo A, Barra F, Kratochwila C, Paudice M, Vellone VG, Godano E, et al. Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19. Medicina (Kaunas, Lithuania) 2020. https://doi.org/10.3390/medicina56060306.

53.

Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during Pregnancy and Possible Vertical Transmission. Am J Perinatol. 2020;37:861–5. https://doi.org/10.1055/s-0040-1710050.CrossRefPubMedPubMedCentral

54.

Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM, et al. Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM. 2020;2: 100133. https://doi.org/10.1016/j.ajogmf.2020.100133.CrossRefPubMedPubMedCentral

55.

Sacks GP, Studena K, Sargent IL, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80–6. https://doi.org/10.1016/s0002-9378(98)70254-6.CrossRefPubMed

56.

Wei Z-Y, Geng Y-J, Huang J, Qian H-Y. Pathogenesis and management of myocardial injury in coronavirus disease 2019. Eur J Heart Fail. 2020. https://doi.org/10.1002/ejhf.1967.CrossRefPubMed

57.

Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14:513–7. https://doi.org/10.1016/j.dsx.2020.04.049.CrossRefPubMedPubMedCentral

58.

Iqbal A, Prince LR, Novodvorsky P, Bernjak A, Thomas MR, Birch L, et al. Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans. J Clin Endocrinol Metab. 2019;104:1187–99. https://doi.org/10.1210/jc.2018-01168.CrossRefPubMed

59.

Liu H, Wang L-L, Zhao S-J, Kwak-Kim J, Mor G, Liao A-H. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139: 103122. https://doi.org/10.1016/j.jri.2020.103122.CrossRefPubMedPubMedCentral

60.

Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020;10:1271. https://doi.org/10.4081/cp.2020.1271.CrossRefPubMedPubMedCentral

61.

Abbas AM, Ahmed OA, Shaltout AS. COVID-19 and maternal pre-eclampsia: A synopsis. Scand J Immunol. 2020;92: e12918. https://doi.org/10.1111/SJI.12918.CrossRefPubMed

62.

Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis, and new-onset Diabetes: might we envisage any cause-effect relationships among them? Diabetes Obes Metab. 2020. https://doi.org/10.1111/dom.14170.

63.

Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193–9. https://doi.org/10.1007/s00592-009-0109-4.CrossRefPubMed

64.

Braems G. Fetal hypoxemia on a molecular level: adaptive changes in the hypothalamic–pituitary–adrenal (HPA) axis and the lungs. Eur J Obstet Gynecol Reprod Biol. 2003;110:S63–9. https://doi.org/10.1016/S0301-2115(03)00174-X.CrossRefPubMed

65.

Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11:3572. https://doi.org/10.1038/s41467-020-17436-6.CrossRefPubMedPubMedCentral

66.

Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V, et al. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta. EBioMedicine. 2020;59: 102951. https://doi.org/10.1016/j.ebiom.2020.102951.CrossRefPubMedPubMedCentral

67.

Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, et al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63:1440–52. https://doi.org/10.1007/s00125-020-05164-x.CrossRefPubMedPubMedCentral

68.

McIntyre HD, Moses RG. The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care. 2020;43:1433–4. https://doi.org/10.2337/dci20-0026.CrossRefPubMed

69.

Nouhjah S, Jahanfar S, Shahbazian H. Temporary changes in clinical guidelines of gestational diabetes screening and management during COVID-19 outbreak: A narrative review. Diabetes Metab Syndr. 2020;14:939–42. https://doi.org/10.1016/j.dsx.2020.06.030.CrossRefPubMedPubMedCentral

70.

Panaitescu AM, Ciobanu AM, Popa M, Duta I, Gica N, Peltecu G, Veduta A. Screening for Gestational Diabetes during the COVID-19 Pandemic—Current Recommendations and Their Consequences. Medicina. 2021;57:381. https://doi.org/10.3390/medicina57040381.CrossRefPubMedPubMedCentral

71.

van-de-l’Isle Y, Steer PJ, Watt Coote I, Cauldwell M. Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single-centre observational study. BJOG. 2021;128:917–20. https://doi.org/10.1111/1471-0528.16482.CrossRefPubMed

72.

Zhu S, Meehan T, Veerasingham M, Sivanesan K. COVID-19 pandemic gestational diabetes screening guidelines: A retrospective study in Australian women. Diabetes Metab Syndr. 2021;15:391–5. https://doi.org/10.1016/j.dsx.2021.01.021.CrossRefPubMed

73.

Ahn DT. The COVID-19 Pandemic: A “Tech”-tonic Shift Toward Virtual Diabetes Care. J Diabetes Sci Technol. 2020;14:708–9. https://doi.org/10.1177/1932296820929719.CrossRefPubMedPubMedCentral

74.

German Diabetes Association (DDG). Aus der Krise lernen: Digitalisierung und Telemedizin nutzen und Versorgung von Patienten mit Diabetes mellitus verbessern – auch nach der Corona-Pandemie. 2020. https://www.deutsche-diabetes-gesellschaft.de/pressekonferenzen/endstation-notstand-wie-wir-die-weichen-fuer-eine-gute-diabetesversorgung-von-morgen-stellen-1. Accessed 31 Aug 2020.

75.

Farooqi MH. Tele-Management of Diabetes in the Post-COVID-19 Era. Dubai Diabetes Endocrinol J. 2020:1–3. https://doi.org/10.1159/000510273.

76.

Aziz A, Zork N, Aubey JJ, Baptiste CD, D’alton ME, Emeruwa UN, et al. Telehealth for High-Risk Pregnancies in the Setting of the COVID-19 Pandemic. Am J Perinatol. 2020;37:800–8. https://doi.org/10.1055/s-0040-1712121.CrossRefPubMedPubMedCentral

77.

Simon M, Sarkar N, Kumaran S, Chittake A, Purandare V, Unnikrishnan A. Telemedicine for the initial management of newly diagnosed gestational diabetes in the pandemic period: A report of three case studies. J Diabetol. 2020;11:144. https://doi.org/10.4103/JOD.JOD_44_20.CrossRef

78.

Ming W-K, Mackillop LH, Farmer AJ, Loerup L, Bartlett K, Levy JC, et al. Telemedicine Technologies for Diabetes in Pregnancy: A Systematic Review and Meta-Analysis. J Med Internet Res. 2016;18: e290. https://doi.org/10.2196/jmir.6556.CrossRefPubMedPubMedCentral

79.

Moradi F, Ghadiri-Anari A, Enjezab B. COVID-19 and self-care strategies for women with gestational diabetes mellitus. Diabetes Metab Syndr. 2020;14:1535–9. https://doi.org/10.1016/j.dsx.2020.08.004.CrossRefPubMedPubMedCentral

80.

Eberle C, Ament C. Digitale Diabetologie – Eine quantitative Analyse diabetesspezifischer mHealth-Apps. Diabetes Stoffwechsel. 2019. https://doi.org/10.1055/s-0039-1688129.CrossRef

81.

Eberle C. 8. Einsatz neuer Technologien in Diagnostik und Therapie: Diabetes-Smartphone-Apps. In: Stupin J, Schäfer-Graf U, Hummel M, editors. Diabetes in der Schwangerschaft: Praxisorientiertes Wissen zu Gestationsdiabetes, Diabetes mellitus Typ 1 und 2, MODY. 1st ed.; 2020. p. 311–314. https://doi.org/10.1515/9783110569186-008.

82.

Eberle C, Ament C. Diabetes & Schwangerschaft 4.0 – Individualisierte Nutzungsanalyse von mHealth-Apps. Diabetologie Stoffwechsel. 2017;12:S1–84. https://doi.org/10.1055/s-0037-1601701.CrossRef

83.

Eberle C, Ament C. Schwangerschaft und Digitalisierung – Individualisierte Nutzungsanalyse von Schwangerschafts- und GDM-Apps. Diabetes Stoffwechsel. 2019. https://doi.org/10.1055/s-0039-1688270.CrossRef

84.

Albert L, Capel I, García-Sáez G, Martín-Redondo P, Hernando ME, Rigla M. Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine. Diabetes Res Clin Pract. 2020;169: 108396. https://doi.org/10.1016/j.diabres.2020.108396.CrossRefPubMedPubMedCentral

Title: SARS-CoV-2 in diabetic pregnancies: a systematic scoping review
Authors: Claudia Eberle
Tamarra James-Todd
Stefanie Stichling
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: SARS-CoV-2
COVID-19
Pre-Eclampsia
Diabetes
Published in: BMC Pregnancy and Childbirth / Issue 1/2021
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-021-03975-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

SARS-CoV-2 in diabetic pregnancies: a systematic scoping review

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Umbilical artery thrombosis diagnosed at different gestational ages and fetal outcomes: a case series

Comparative epidemiology of gestational diabetes in ethnic Chinese from Shanghai birth cohort and growing up in Singapore towards healthy outcomes cohort

The perception of Italian pregnant women and new mothers about their psychological wellbeing, lifestyle, delivery, and neonatal management experience during the COVID-19 pandemic lockdown: a web-based survey

Perceived differences on the role of traditional birth attendants in rural Tanzania: a qualitative study

Fetal growth velocity references from a Chinese population–based fetal growth study

Non-invasive fetal electrocardiography, electrohysterography and speckle-tracking echocardiography in the second trimester: study protocol of a longitudinal prospective cohort study (BEATS-study)